Citadel Advisors
CHAQ.U

Citadel Advisors’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Citadel Advisors’s Portfolio CHAQ.U Stock Details CHAQ.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-301,231
Closed -$3.27M – 15263
2021
Q2 		$3.27M Buy
301,231
+600
+0.2% +$6.34K ﹤0.01% 5393
2021
Q1 		$3.31M Sell
300,631
-2,049
-0.7% -$23.3K ﹤0.01% 5206
2020
Q4 		$3.21M Buy
302,680
+10
+0% +$105 ﹤0.01% 4487
2020
Q3 		$3.19M Sell
302,670
-399
-0.1% -$4.16K ﹤0.01% 3879
2020
Q2 		$3.18M Buy
+303,069
New +$3.04M ﹤0.01% 3755

Citadel Advisors's CHAQ.U Position: Q3 2021 in Review

Citadel Advisors sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 301,231 shares — an estimated $3.27M sold.

Citadel Advisors first reported a position in CHAQ.U in Q2 2020 and held it in 5 quarters. The position peaked at $3.31M in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

  • Citadel Advisors reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
  • Citadel Advisors sold 301,231 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021, an estimated $3.27M.
  • Citadel Advisors first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 5 quarters.
  • Citadel Advisors's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $3.31M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.